The Only Non-Invasive & Continuous CVP Monitoring System

Breakthrough Transformation in Hemodynamic Monitoring

Mespere uses Near Infrared Spectroscopy (NIRS) technology to measure venous hemodynamics without the need for invasive catheterization.

Mespere non-invasive sensors shine near infrared photons into the tissue containing jugular venous blood vessels and analyze the diffusely reflected photons to determine central venous pressure.

VENUS 2000 CVP is ideal for use in:

  • Emergency
  • ICU
  • Long Term Care
  • Heart Failure Clinics

Understanding preload and volume status is critical for the delivery of effective acute care in a number of disease states. The VENUS 2000 has the ability to assess this, reliably and accurately, in a continuous, non-invasive manner and therefore is an important advance that removes many of the challenges associated with existing approaches.

Dr. Phillip Levy, MD, MPH, FACEP, FAHA
Professor of Emergency Medicine and Physiology Associate Chair for Research, Department of Emergency Medicine Director, Clinical Research Service Center, Wayne State University School of Medicine

Preload & Volume Status Pressure Monitoring


Accuracy *

Continuous Monitoring


Visual Waveform

Low Cost

Set-Up by Nurse


No Risk of Infection

Fast & Easy to Use

* Journal of Cardiac Failure, 2013; 19 (8) Suppl.: S51


Description Item Code Qty

VENUS 2000 Sensor



VENUS 2000 Adhesives (Single Use)



Reference Holder



Mespere Operating System



Mespere Display Monitor



Monitor Mount



Docking Station & Mount



For a PDF version, please download this document.

CVP Physiology

Central Venous Pressure (CVP) is the clinical measurement of right atrial pressure. It is used to evaluate the adequacy of circulating blood volume and cardiac preload. Central venous pressure is comprised of the pressure generated by the volume of blood returning to the right atrium and the pressure adjacent to the heart, called juxta-cardiac pressure. The gradient between mean systemic filling pressure and CVP creates venous return and cardiac output 1.

Venous return is the rate that blood returns to the heart. Mean systemic filling pressure, right atrial pressure, and vascular resistance all play a key role in venous return. Cardiac output correlates with the function and performance of the heart. Ventricular afterload, autonomic tone, and many intrinsic factors affect cardiac output.

Any factor that causes a change in venous return and/or cardiac output can greatly influence CVP. An elevated CVP may be due to an impediment to venous return, hyperinflation, venous return has exceeded the limit of cardiac accommodation, dysfunction in the right heart or obstruction to right ventricular outflow - causing retention of blood, renal failure, or hepatic dysfunction. A lower CVP could be a response to venodilation - causing low venous return, volume loss, sympatholysis, or from any cardiac function that encourages the ejection of blood 1-4.

Due to the fact that CVP is very responsive to any change in venous return or cardiac output, it has shown to be an important measurement to integrate with other monitoring techniques, to better evaluate the patient's hemodynamic instability and to confirm a preliminary diagnosis. It has been used in the ICU for hemodynamic intervention, and bedside for interpretation of a bedside echocardiogram 4.

Current Method

Currently the common practiced method for attaining CVP is by invasive central venous catheter. Many risks and complications are associated with central venous catheters therefore it would be an attractive option to have a non-invasive technique. Mespere LifeSciences has developed a novel device to continuously monitor CVP non-invasively.

The Mespere VENUS 2000 CVP system will help make the physical examination of CVP an easier and reliable process for the physician. In addition, the Mespere VENUS 2000 CVP system will have the additional benefits of allowing physicians to continuously asses CVP over a period of time and to observe the plethysmographic waveform, a feature not available with physical examination.

Interpreting a Change in CVP Measurement

Normal range for CVP is between 4-12 cmH 2O or 3-8 mmHg. A CVP reading outside of this range should be monitored, and appropriate measures should be taken to get the CVP back into the normal range.


  1. Berlin, D.A., Bakker, J. (2015) Starling curves and central venous pressure. Critical Care, 19:55. DOI 10.1186/s13054-015-0776-1
  2. Jacobsohn, E., R. Chorn, and M. OConnor, The role of the vasculature in regulating venous return and cardiac output: historical and graphical approach. Canadian Journal of Anaesthesia-Journal Canadien D Anesthesie, 1997. 44(8): p. 849-867.
  3. Funk, D.J., E. Jacobsohn, and A. Kumar, The role of venous return in critical illness and shock-part I: physiology. Crit Care Med, 2013. 41(1): p. 255-62.
  4. Kenny, J-E.S., ICU Physiology in 1000 Words: In Defense of the Central Venous Pressure. Crit Care Med, 2014.

Accuracy of the Mespere VENUS 2000 CVP System Compared to Catheters

Current risks involved with taking continuous CVP measurements, are catheter placement and maintenance. Catheters are susceptible to conflicting results due to, the rate that fluids are introduced, head positioning, and correct tip placement 1. The current precision for commonly used catheters is -0.1±3.5 cmH 2O 2. Contrary to catheters, the Mespere VENUS 2000 CVP is not susceptible to these risks since it is non-invasive, and there is no placement or insertion of a catheter. The accuracy and precision of the Mespere VENUS 2000 CVP is ± 1.35 cmH 2O or ±1 mmHg, therefore it is more precise than the current traditionally practiced method for attaining CVP.

Clinical Applications of Non-Invasive CVP

The Mespere VENUS 2000 CVP system is indicated for individuals to measure hemodynamic cardiac pressures in the human body to allow physicians to better understand cardiovascular health. The Mespere VENUS 2000 CVP system should be used by health care professionals as a non-invasive, spot-checking and/or continuous monitoring tool for physical assessment of central venous pressure (CVP) of an individual. This is done via an adhesive neck sensor placed over the external jugular vein. The device is intended for use in hospital and clinical environments.

The Mespere VENUS 2000 CVP System is ideal for preload and volume status assessment and monitoring for patients with congestive heart failure, sepsis, renal failure, congenital heart disease etc. It can be used in a variety of settings including Emergency Departments, Intensive Care Units, Heart Failure Clinics, and Long Term Care Facilities.


  1. Chatterjee, K. (2007) Physical Examination. In E.J. Topol (Ed.), Textbook of Cardiovascular Medicine (3rd Edition ed., pp. 1993-224). Philadelphia: Lippincott Williams & Wilkins
  2. Thalhammer, C., Ashwanden, M., Odermatt, A., Baumann, U., Imfeld, S., Bilecen, D., Marsch, S., Jaeger, K., Noninvasive Central Venous Pressure Measurement by Controlled Compression Sonography at the Forearm. Journal of the American College of Cardiology, 2007. 0735-1097